Biotricity, Inc. is a medical technology company, which engages in biometric data monitoring solutions. The company is headquartered in Redwood City, California and currently employs 46 full-time employees. The company went IPO on 2015-10-26. The firm developed its Bioflux COM technology, comprised of a monitoring device and software components. Its Bioflux and Biocore Pro are integrated electrocardiogram (ECG) device and software solutions for the COM market. The Biocore ECG reporting software allows doctors and labs to view a patient’s ECG data for monitoring and diagnostic purposes. The Bioflux and Biocore Pro platform has a built-in cellular chipset and a real-time embedded operating system which allows its technology to be utilized as an Internet of Things (IoT) platform. The firm has developed several technologies, including Bioheart, Biocare, and Biokit. Biokit is a remote patient monitoring kit that combines a blood pressure cuff, pulse oximeter and a digital thermometer into the Biocare platform to support the collection of additional biometrics for those patients with multiple conditions.
Mr. Waqaas Al-Siddiq 2016 'den beri şirketle birlikte olan Biotricity Inc 'in Chairman of the Board 'ıdır.
BTCY hissesinin fiyat performansı nasıl?
BTCY 'in mevcut fiyatı $0.2464 'dir, son işlem günde 1.38% giảm etti.
Biotricity Inc için ana iş temaları veya sektörler nelerdir?
Biotricity Inc Health Care endüstrisine ait ve sektör Health Care 'dir
Biotricity Inc 'in piyasa değerlemesi nedir?
Biotricity Inc 'in mevcut piyasa değerlemesi $7.0M 'dir
Biotricity Inc al, sat, yoksa beklemeli mi?
Wall Street analistlerine göre, 3 analist Biotricity Inc için analist derecelendirmeleri gerçekleştirdi, bunlar 0 güçlü al, 0 al, 3 tut, 1 sat ve 0 güçlü sat içermektedir